disease

A young woman ultimately diagnosed with a brain tumor claims "crippling headaches" were repeatedly dismissed as migraines. Headaches come in many forms, from benign to unsettling. So what are the red flags?
Given therapeutics in the cancer category dominate the list is not so surprising, given the hefty price tag they yield. Where there is a great return there tends to be a great investment.
There's a reason that it's a running joke. You know, the one that medical students go through a phase when they think they actually have every disease they study. But for those not in the profession, preoccupation with illness is reaching unhealthy levels.
Telling your doctor you were fully compliant, when you weren’t, is pretty standard fare. From tiny fibs to outright self-sabotage, how we cope with a bump in the health road determines how difficult we make the ride.
With cancer death rates declining 27% over a quarter century, there's much cause for celebrating. But now, complacency is not an option.
Information is like any other medical therapy. When it's within a therapeutic range, it can be curative. But at toxic levels, it can be destructive. Its quantity will never trump its quality.
Every year, 5.6 million children under the age of 5 die. That's roughly the same size as the entire Atlanta metropolitan area. Imagine a city that size filled only with children aged 4 and younger. Now, imagine that city being wiped off the map. Every year. That's the scope of the problem that global poverty presents.
This year brought about a number of public debates surrounding not only less-mainstream medical conditions, but also others that were emotionally challenging and ethically complex. Check out which ones made this Top-10 list.
Global public health
A team of international researchers, in collaboration with the World Health Organization, recently assessed the share of global disease burden that was directly attributable to environmental risks. Their findings were published in the Journal of Public Health.
Last month's decision from the American Medical Association to label obesity as a disease has sparked much public criticism, and understandably so. A fresh perspective on the issue and one that shouldn t be ignored, comes from a Forbes op-ed by Dr. Geoffrey Kabat published today.